@sirius007 IMO It is a short attack that is taking advantage of some temporary doubt in the markets based on a slightly lower growth number in sales. The variation is not in my mind troubling as I have listened to the whole presentation. It is not due to a fundamental change IMO such as TAM, customer adoption or management quality The company is selling to more devices to customers and has a new market growing for MTX which is a smaller device. This will build in volume and according to the management will become the major product to markets that are maturing such as US. That along with continued "lumpiness" during the growth is the main issue. Burns will continue to grow and evolve in multiple markets but will reach a steady state at some point in various jurisdictions under normal conditions). I expect the growth will continue varying and be less predictable for a while as not only markets are grown but different products are released (Hernia and breast are moving along nicely). That said we are still selling more devices to more people as each month/quarter and year passes. This is moving into a volume player with very good margins.
That means my core holding is not changing unless I get some bonus shares in the current drop.
PNV Price at posting:
$1.53 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)